Skip to content

Acute Myeloid Leukemia By Fab Classification C5679583

Published: July 22, 2026Updated: August 20, 2026

A classification system for acute myeloid leukemia based on how the abnormal cells appear under a microscope. This system helps categorize AML into subtypes that guide treatment decisions. It was widely used historically and remains relevant for understanding certain subtypes.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C96.9
ICD-11
2A00.0
Body system
hematologic
Severity
critical
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Generalized symptoms

Symptoms may be severe and require urgent medical attention.

Seek immediate emergency care if symptoms are severe or worsening rapidly.

Fatigue

(hematologic)

Fever

(hematologic)

Easy bruising

(hematologic)

Bone pain

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Elective procedure with pre- and post-procedure care

Requires immediate emergency medical intervention. Do not delay treatment.

procedure
2

Intensive Induction Chemotherapy

High-dose cytarabine combined with anthracycline therapy as first-line treatment for newly diagnosed AML, designed to achieve complete morphologic remission.

medication
3

Allogeneic Bone Marrow Transplant

Potentially curative procedure involving infusion of donor stem cells after myeloablative or reduced-intensity conditioning, considered after achieving remission.

surgical

Additional treatment options

Consolidation Chemotherapy

Additional cycles of chemotherapy following induction to eliminate remaining leukemic cells and prevent relapse, typically using high-dose cytarabine.

medication

Central Line Placement and Management

Implantation of tunneled catheters or ports for long-term venous access, facilitating chemotherapy administration, blood products, antibiotics, and frequent blood draws.

procedure

Infection Prevention Practices

Education and implementation of infection control measures including hand hygiene, environmental precautions, and avoidance of crowds during neutropenic periods.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Call emergency services (911) immediately

!

Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.

Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.

Frequently asked questions

Common questions about this topic.

Q

What is Acute Myeloid Leukemia By Fab Classification C5679583?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Dohner H, Weisdorf DJ, Bloomfield CD. Acute Myeloid Leukemia: Clinical Practice Guidelines Update. Blood. 2022.

guideline2022
2

Khwaja A, Bjorkholm M, Gale RE. Acute Myeloid Leukemia: A Comprehensive Review. Lancet Oncol. 2021.

review2021
3

Stein EM, Tallman MS, Lowenberg B. Novel Agents in AML: Results from Phase III Clinical Trial. J Clin Oncol. 2023.

clinical_trial2023
4

Wang ES, Lichtenfeld R, de Lima M. Stem Cell Transplantation in AML: Meta-Analysis of Outcomes. Haematologica. 2020.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Acute Myeloid Leukemia By Fab Classification C5679583. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy